Table 1. Characteristics of 235 patients undergoing thymoma resection.
Variables | Number | Percentage (%) |
---|---|---|
Age, median (range), years | 51.00 (20–85) | |
Gender | ||
Male | 103 | 43.83 |
Female | 132 | 56.17 |
Surgical approach | ||
Median sternotomy | 145 | 61.70 |
Thoracotomy | 40 | 17.02 |
VATS | 50 | 21.28 |
Extent of resection | ||
Thymomectomy | 90 | 38.30 |
Extended thymothymectomy | 145 | 61.70 |
Completeness of resection | ||
R0 | 228 | 97.02 |
R1 | 2 | 0.85 |
R2 | 5 | 2.13 |
Myasthenia Gravis (MG) | ||
With MG | 75 | 31.91 |
Without MG | 160 | 68.09 |
WHO histological types | ||
A | 19 | 8.10 |
AB | 69 | 29.36 |
B1 | 56 | 23.83 |
B2 | 50 | 21.28 |
B3 | 41 | 17.45 |
Masaoka stage | ||
I | 65 | 27.66 |
II | 138 | 58.72 |
III | 21 | 8.94 |
IV | 11 | 4.68 |
Tumor size, median (range), cm | 6.0 (1.5–16.0) | |
Adjuvant therapy | ||
None | 133 | 56.60 |
Radiotherapy | 99 | 42.13 |
Chemoradiation | 3 | 1.28 |
Mortality | ||
Yes | 13 | 5.56 |
No | 221 | 94.44 |
Recurrence | ||
Yes | 25 | 10.68 |
No | 209 | 89.32 |
VATS: Video-assisted thoracoscopic surgery
MG: Myasthenia Gravis